Tonix Pharmaceuticals Holding Corp. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6.9M | 5.4M | 3.3M | 2.0M | 2.4M | 2.6M | 2.8M | 2.2M |
| Cost of Goods Sold | 2.1M | 1.5M | 1.4M | 3.3M | 943K | 1.2M | 1.6M | 3.4M |
| Gross Profit | 4.7M | 3.8M | 1.9M | -1.3M | 1.5M | 1.4M | 1.3M | -1.2M |
| R&D Expenses | 18.2M | 16.9M | 9.3M | 10.8M | 7.4M | 8.3M | 9.1M | 9.7M |
| Operating Expenses | 46.3M | 52.1M | 35.0M | 27.0M | 17.5M | 23.9M | 16.8M | 17.2M |
| Operating Income | -41.5M | -48.3M | -33.1M | -28.3M | -16.1M | -22.5M | -15.6M | -18.4M |
| Other Income / Gains | 1.3M | 1.4M | 1.1M | 24K | -775K | 372K | 1.3M | -60.4M |
| Net Income | -40.2M | -46.9M | -32.0M | -28.3M | -16.8M | -22.1M | -14.2M | -78.8M |
| EPS (Diluted) | -2.93 | -4.28 | -3.59 | -3.86 | -2.84 | -9.77 | -0.23 | -2K |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.69 | 0.713 | 0.584 | -0.638 | 0.612 | 0.542 | 0.449 | -0.525 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 10.1M | 3.4M | 0 | 7.5M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 12.2M | 0 | 0 |
| Selling General And Administrative Expenses | 28.1M | 35.2M | 0 | 0 | 10.1M | 15.6M | 0 | 7.5M |
| Other Expenses | 0 | 0 | 25.7M | 16.2M | 0 | 0 | 7.7M | 0 |
| Cost And Expenses | 48.4M | 53.7M | 36.4M | 30.3M | 18.5M | 25.1M | 18.4M | 20.6M |
| Interest Income | 1.3M | 1.3M | 1.2M | 943K | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 555K | 488K | 461K | 483K | 493K | 496K | 510K | 1.2M |
| Ebitda | -39.6M | -46.4M | -31.5M | -27.8M | -16.3M | -21.6M | -13.7M | -77.6M |
| Ebitdaratio | -5.763 | -8.613 | -9.589 | -13.908 | -6.725 | -8.37 | -4.856 | -35.132 |
| Operating Income Ratio | -6.039 | -8.958 | -10.051 | -14.162 | -6.609 | -8.706 | -5.512 | -8.315 |
| Income Before Tax | -40.2M | -46.9M | -32.0M | -28.3M | -16.8M | -22.1M | -14.2M | -78.8M |
| Income Before Tax Ratio | -5.844 | -8.703 | -9.729 | -14.15 | -6.928 | -8.562 | -5.036 | -35.678 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -5.844 | -8.703 | -9.729 | -14.15 | -6.928 | -8.562 | -5.036 | -35.678 |
| Epsdiluted | -2.93 | -4.28 | -3.59 | -3.86 | -2.84 | -9.77 | -0.23 | -2K |
| Weighted Average Shs Out | 13.7M | 8.5M | 8.9M | 7.3M | 5.9M | 2.3M | 6.2M | 4.1M |
| Weighted Average Shs Out Dil | 13.7M | 8.5M | 8.9M | 7.3M | 5.9M | 2.3M | 6.2M | 4.1M |